Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC
Clinical trial NCT02394015 · COMPLETED
Trial details
- NCT number
- NCT02394015
- Sponsor
- Grupo Español de Investigación en Cáncer de Ovario
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-06
- Primary completion
- 2017-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.